Aimei Health Seeks Shareholder Vote to Extend SPAC Deadline to December 2027
AFJK sits 78% above its 52-week low of $6.75 on light trading volume (0.1× avg).
Summary
Aimei Health is seeking shareholder approval to extend its SPAC business combination deadline by 12 months to December 6, 2027, offering public shareholders a redemption at approximately $12.25 per share.
Key Events · Corporate Governance and Compliance · AFJK
-
12-Month Deadline Extension Proposed
Shareholders will vote on November 10, 2026 to extend the business combination deadline from December 6, 2026 to December 6, 2027, requiring a special resolution with two-thirds approval.
-
Redemption Offer at $12.25 Per Share
Public shareholders may redeem shares at approximately $12.25 per share, based on the trust account balance of $12,740,939.68 as of October 2, 2026, with a redemption deadline of November 6, 2026.
-
United Hydrogen Merger Terminated
The prior business combination with United Hydrogen was terminated on July 7, 2026 after the CSRC failed to grant required approval, leaving the SPAC without a target.
-
Insider Control of Vote
Sponsor, directors, and officers control 2,057,000 shares (64.96% of outstanding) and are expected to vote in favor of the extension, making approval highly likely.
Analysis · AFJK · Real Estate & Construction
Aimei Health is asking shareholders to approve a 12-month extension of its business combination deadline from December 6, 2026 to December 6, 2027. The SPAC's prior merger with United Hydrogen collapsed in July 2026 after Chinese regulatory approval never came, and the company now faces liquidation if it cannot find a new target. The proxy offers public shareholders a redemption at approximately $12.25 per share, slightly above the $12.11 closing price on the record date, giving investors a near-cash exit. Insiders control 64.96% of the vote and will support the extension, so approval is likely. The key risk is that redemptions could drain the trust account, leaving the company with insufficient capital to complete any future deal.
How filings like this one have moved
In the 30 days to Oct 9, 2026, 28.8% of the 1682 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.53%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, AFJK was trading at $12.02 on NASDAQ in the Real Estate & Construction sector, with a market capitalization of approximately $38.3M. The 52-week trading range was $6.75 to $130.37. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.